Have a personal or library account? Click to login
Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis Cover

Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis

Radiology and Oncology
Volume 56 (2022): Issue 4 (December 2022)
By: Vlatko Potkrajcic,  Arndt-Christian Mueller,  Bettina Frey,  Cihan Gani,  Daniel Zips,  Ruediger Hoffmann,  Sandra Frantz,  Verena Warm,  Frank Paulsen and  Franziska Eckert  
Open Access
|Dec 2022

Authors

Vlatko Potkrajcic

vlatko.potkrajcic@med.uni-tuebingen.de

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany

Arndt-Christian Mueller

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany
RKH-Kliniken Ludwigsburg, Department of Radiation Oncology and Radiotherapy, Ludwigsburg, Germany

Bettina Frey

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany

Cihan Gani

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany

Daniel Zips

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany
German Cancer Consortium (DKTK) Partnersite Tuebingen, German Cancer Research Center (DKFZ), Heidelberg, Germany
Charité University Hospital, Department of Radiation Oncology and Radiotherapy, Berlin, Germany

Ruediger Hoffmann

Eberhard-Karls-University Tuebingen, Department for Radiology, Tuebingen, Germany

Sandra Frantz

Eberhard-Karls-University Tuebingen, Department of Orthopaedic Surgery, Tuebingen, Germany

Verena Warm

Eberhard-Karls-University Tuebingen, Department of Pathology, Tuebingen, Germany

Frank Paulsen

frank.paulsev@med.uni-tuebingen.de

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany

Franziska Eckert

Eberhard-Karls-University Tuebingen, Department of Radiation Oncology, Tuebingen, Germany
German Cancer Consortium (DKTK) Partnersite Tuebingen, German Cancer Research Center (DKFZ), Heidelberg, Germany
Medical University Vienna, AKH, Comprehensive Cancer Center, Department of Radiation Oncology, Wien, Austria
DOI: https://doi.org/10.2478/raon-2022-0053 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 515 - 524
Submitted on: Jul 26, 2022
Accepted on: Oct 11, 2022
Published on: Dec 13, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
radiotherapy,
oligometastatic disease,
oligoprogressive disease,
bone metastases,
hypofractionated radiotherapy,
simultaneous integrated boost
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Vlatko Potkrajcic, Arndt-Christian Mueller, Bettina Frey, Cihan Gani, Daniel Zips, Ruediger Hoffmann, Sandra Frantz, Verena Warm, Frank Paulsen, Franziska Eckert, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 56 (2022): Issue 4 (December 2022)Next article